Athelas
For healthcare providers seeking administrative efficiency and patients managing chronic conditions through remote monitoring.
Snapshot
Who is Athelas?
Automating clinical documentation and health monitoring for providers and patients. Bridging the gap between patient data and EHR systems.
Target audience
Rivals analysis in progress
Portfolio
Free 3Last updated
Commure Ambient - ScribeMobile
v3.28.1
6mo ago
Publisher DNA
What defines Athelas?
Publisher DNA
Primary focus
Medical and Health & Fitness software
Scale
indie
Target audience
Healthcare providers seeking administrative efficiency and patients managing chronic conditions through remote monitoring.
Signature Patterns
- •Focus on clinical and health-related utility applications
- •Integration-heavy architecture connecting mobile apps to EHR or hardware systems
- •Free-to-access pricing model across the portfolio
- •Shift toward AI-driven automation for professional healthcare workflows
Portfolio momentum
With 10 releases in the last 6 months and active development on their flagship medical scribe tool, the publisher is currently in an intense development phase.
Portfolio
What does Athelas ship?
Apps
3 apps analysed
Single-market publisher, every app ships only to United States.
Based on 1 of 3 apps with localized market data, more coverage rolling in as scans complete · last scanned .
Americas (1)
- United States1 / 1
Core markets (1/1 apps)
The Analyst's Read
The bottom line on Athelas
Bottom line
Athelas Inc. is successfully transitioning from a niche health-tracking developer to an enterprise-integrated medical software provider. Their focus on reducing administrative burden for clinicians provides a clear, high-value path for future growth.
Frequently asked questions
How many apps does Athelas publish?
What kind of apps does Athelas make?
What is Athelas's top app?
In how many countries are Athelas's apps available?
What fed this analysis
- Apps analyzed:
- 3
- With full intel:
- 0
- With overview:
- 3
- Website scraped:
- yes
- Social presence:
- yes